4-(2,3-dimethylimidazol-4-yl)-6-(4-fluoro-1,3-thiazol-2-yl)-2-(2-methoxyethylsulfinyl)thieno[2,3-b]pyridin-3-amine
C18H18FN5O2S3 — CID 118059071
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(2,3-dimethylimidazol-4-yl)-6-(4-fluoro-1,3-thiazol-2-yl)-2-(2-methoxyethylsulfinyl)thieno[2,3-b]pyridin-3-amine
4-(2,3-dimethylimidazol-4-yl)-6-(4-fluoro-1,3-thiazol-2-yl)-2-(2-methoxyethylsulfinyl)thieno[2,3-b]pyridin-3-amine (PubChem CID 118059071) has the molecular formula C18H18FN5O2S3 and a molecular weight of 451.57 g/mol. Its IUPAC name is 4-(2,3-dimethylimidazol-4-yl)-6-(4-fluoro-1,3-thiazol-2-yl)-2-(2-methoxyethylsulfinyl)thieno[2,3-b]pyridin-3-amine.
Molecular Properties
| Compound Name | 4-(2,3-dimethylimidazol-4-yl)-6-(4-fluoro-1,3-thiazol-2-yl)-2-(2-methoxyethylsulfinyl)thieno[2,3-b]pyridin-3-amine |
|---|---|
| PubChem CID | 118059071 |
| Molecular Formula | C18H18FN5O2S3 |
| Molecular Weight | 451.57 g/mol |
| Exact Mass | 451.06 |
| IUPAC Name | 4-(2,3-dimethylimidazol-4-yl)-6-(4-fluoro-1,3-thiazol-2-yl)-2-(2-methoxyethylsulfinyl)thieno[2,3-b]pyridin-3-amine |
| SMILES | COCCS(=O)c1sc2nc(-c3nc(F)cs3)cc(-c3cnc(C)n3C)c2c1N |
| InChI | InChI=1S/C18H18FN5O2S3/c1-9-21-7-12(24(9)2)10-6-11(16-23-13(19)8-27-16)22-17-14(10)15(20)18(28-17)29(25)5-4-26-3/h6-8H,4-5,20H2,1-3H3 |
| InChIKey | GLJKBEAKYAHVTO-UHFFFAOYSA-N |
| XLogP | 3.60 |
| TPSA | 95.92 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 451.57 |
| LogP ≤ 5 | 3.60 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118059071 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.